ES8602640A1 - Procedimiento de preparar derivados cisteinicos - Google Patents

Procedimiento de preparar derivados cisteinicos

Info

Publication number
ES8602640A1
ES8602640A1 ES534958A ES534958A ES8602640A1 ES 8602640 A1 ES8602640 A1 ES 8602640A1 ES 534958 A ES534958 A ES 534958A ES 534958 A ES534958 A ES 534958A ES 8602640 A1 ES8602640 A1 ES 8602640A1
Authority
ES
Spain
Prior art keywords
acetylcysteine
difluoro
diphenyl
inflammatory
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534958A
Other languages
English (en)
Other versions
ES534958A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Guidotti SpA
Original Assignee
Laboratorio Guidotti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Guidotti SpA filed Critical Laboratorio Guidotti SpA
Publication of ES8602640A1 publication Critical patent/ES8602640A1/es
Publication of ES534958A0 publication Critical patent/ES534958A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS CISTEINICOS, EN PARTICULAR PARA LA PREPARACION DE COMPUESTOS DE FORMULA GENERAL (I), EN LA QUE R Y R REPRESENTAN RADICALES TALES COMO COCH3, COOC2H5 O COOCH2 CCL3, Y SUS SALES NO TOXICAS Y FARMACEUTICAMENTE ACEPTABLES CON BASES ORGANICAS E INORGANICAS. CONSISTE EN TRANSFORMAR ELACIDO 2, 4-DIFLUORO-4-HIDROXI-(1,1-BIFENIL)-3-CARBOXILICO EN EL CORRESPONDIENTE ANHIDRIDO MIXTO, MEDIANTE TRATAMIENTO CON ALQUILCLOROCARBONATO, Y A SU VEZ EL ANHIDRIDO MIXTO, POR REACCION CON N-ACETILCISTEINA, SE CONVIERTE EN EL TIOESTER O-ALQUILCARBONATO, A PARTIR DEL CUAL POR HIDROGENOLISIS, SE OBTIENE EL COMPUESTO DESEADO. DE APLICACION EN EL TRATAMIENTO DE LAS AFECCIONES CATARRALES.
ES534958A 1983-08-09 1984-08-08 Procedimiento de preparar derivados cisteinicos Granted ES534958A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8322486A IT1206515B (it) 1983-08-09 1983-08-09 N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche.

Publications (2)

Publication Number Publication Date
ES8602640A1 true ES8602640A1 (es) 1985-12-16
ES534958A0 ES534958A0 (es) 1985-12-16

Family

ID=11196917

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534958A Granted ES534958A0 (es) 1983-08-09 1984-08-08 Procedimiento de preparar derivados cisteinicos

Country Status (9)

Country Link
EP (1) EP0144519B1 (es)
JP (1) JPS6067458A (es)
KR (1) KR920000374B1 (es)
AT (1) ATE27699T1 (es)
BE (1) BE900328A (es)
DE (1) DE3464134D1 (es)
ES (1) ES534958A0 (es)
FR (1) FR2550530B1 (es)
IT (1) IT1206515B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090298923A1 (en) * 2008-05-13 2009-12-03 Genmedica Therapeutics Sl Salicylate Conjugates Useful for Treating Metabolic Disorders
WO2010106083A1 (en) * 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Combination therapies for treating metabolic disorders
WO2010106082A1 (en) 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
AU2012307257B8 (en) 2011-09-16 2017-11-16 Genmedica Therapeutics Sl Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
WO2013037984A1 (en) 2011-09-16 2013-03-21 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068398B2 (es) * 1969-10-07 1973-01-12 Rech Pharmac Scientif
BE794952A (fr) * 1972-02-03 1973-08-02 Bristol Myers Co N-acetyl-l-cysteinate d'ammonium et procede pour le preparer
IT1194117B (it) * 1981-11-20 1988-09-14 Isnardi Pietro & C Spa Derivati salicilici di n-acetilcisteina

Also Published As

Publication number Publication date
KR850001732A (ko) 1985-04-01
JPH051788B2 (es) 1993-01-11
KR920000374B1 (ko) 1992-01-13
JPS6067458A (ja) 1985-04-17
ATE27699T1 (de) 1987-06-15
BE900328A (fr) 1984-12-03
IT8322486A0 (it) 1983-08-09
FR2550530A1 (fr) 1985-02-15
FR2550530B1 (fr) 1987-01-23
ES534958A0 (es) 1985-12-16
EP0144519A1 (en) 1985-06-19
EP0144519B1 (en) 1987-06-10
DE3464134D1 (en) 1987-07-16
IT1206515B (it) 1989-04-27

Similar Documents

Publication Publication Date Title
SE9402558D0 (sv) Ny användning av azatricykloderivat och farmaceutiska kompositioner innehållande desamma
UY26139A1 (es) Composiciones de medicamentos a base de compuestos anticolinérgicamente activos y beta- miméticos
ES479271A1 (es) Un procedimiento para la preparacion de compuestos derivados de acido tioetianico.
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
IT1127322B (it) Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
SE8400332L (sv) Forening for anvendning som mellanprodukt vid framstellning av lekemedel
DK342989D0 (da) Betaendelseshaemmende middel
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
IE802589L (en) Anti-inflammatory pharmaceutical composition containing¹rosmarinic acid
SE9401005L (sv) Farmaceutisk komposition med analgetisk aktivitet
ES8602640A1 (es) Procedimiento de preparar derivados cisteinicos
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
AU530678B2 (en) Phosphono-hydroxy-acetic acid
IT1164387B (it) Derivati n-sostituiti dell'1-(4'-alchilsulfonilfenil)-2-ammino-1,3-propandiolo
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
MY100483A (en) Niflumic acid morpholinoethyl ester diniflumate, preparation, use in therapeutics as analgesic and anti- inflammatory
ES386308A1 (es) Un procedimiento para la preparacion de productos a base demetobromuro de n-iropropil-noratropinio.
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
GB1154454A (en) New Anthranilic Acid Derivatives
ATE44461T1 (de) Analgetische zusammensetzungen.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519